Evaluation of the effectiveness and impact of Nirsevimab in Galicia
The NIRSE-GAL study shows in real time the evolution of the coverage achieved by immunisation with Nirsevimab in children and compares RSV admissions in different population groups of children and adults in Galicia in Spain with previous years.
First results in using new tools to tackle respiratory syncytial virus
Protecting infants from RSV with new tools: vaccines for pregnant women and use of monoclonal antibodies have been approved for use in the European Union to prevent RSV among young children. Are those tools working?
mRNA SARS-CoV-2 Vaccination Before vs During Pregnancy and Omicron Infection Among Infants
Infants younger than 6 months are at risk of severe SARS-CoV-2 infection.
Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants
Whether vaccination during pregnancy could reduce the burden of RSV associated lower respiratory tract illness in newborns and infants is uncertain.
|
ESWI Airborne: Meet the Members
How does a virus cause disease after transmission?
In this fascinating episode pathomechanism is explained and we learn how recent research has shown that acute virus infections may cause long-term health impairments. Even mild flu during pregnancy can affect susceptibility to disease in offspring.
|
ESWI Airborne: Meet the Members
Vaccinations to consider before, during, and after pregnancy
Dr George Kassianos, ESWI Board Member and retired general practitioner gives a comprehensive and in-depth explanation of vaccination and pregnancy, including the risks and benefits to the mother and the infant.
Vaccination in a COVID-19 era
First webinar in the series: Preparing for COVID-19, RSV disease and Inlfuenza concomitant outbreaks, chaired by Ab Osterhaus and Sylvie ...
